Rheumatoid arthritis (RA) is a chronic systemic autoimmune inflammatory disease strongly associated with premature atherosclerosis and an increased risk of cardiovascular diseases (CVDs). Consequently, there is growing clinical concern regarding perioperative and postoperative outcomes in patients with RA undergoing major cardiac surgery. To synthesize the available evidence, a literature search was conducted in PubMed, Scopus, and Google Scholar using the following search terms: “rheumatoid arthritis and coronary artery bypass grafting” and “rheumatoid arthritis and valve surgery”. The initial search identified 28 relevant records. After rigorous screening of titles, abstracts, and full texts, we selected seven articles that met all predefined eligibility criteria for detailed qualitative synthesis. The reviewed evidence suggests that patients with RA undergoing cardiac surgery may face an increased risk of adverse outcomes, including in-hospital mortality, postoperative myocardial infarction (MI), impaired sternal wound healing, and infection. Crucially, these surgical risks are profoundly exacerbated by preoperative high-dose and prolonged corticosteroid regimens, which impair tissue repair and vascular integrity. Preoperative assessment of disease activity, comorbidities, and complexity can guide medication plans, balancing infection and healing risks with inflammation control. Further prospective studies are needed to refine risk-estimation models and therapeutic protocols. In conclusion, careful postoperative hemodynamic monitoring, multidisciplinary collaboration, and appropriate perioperative management of immunomodulatory medications may help reduce surgical complications and improve outcomes in patients with RA undergoing cardiac surgery.
Type of Study:
Review |
Subject:
Heart Surgery Received: 2026/02/27 | Accepted: 2026/03/6 | ePublished ahead of print: 2026/11/21